Pediatric malignant bone tumors

Overview

Board takeaway: Refer unexplained destructive or expanding jaw lesions promptly and coordinate dental care with diagnosis and oncology treatment.

How do osteosarcoma and Ewing sarcoma differ?

Osteosarcoma is a malignancy in which tumor cells form osteoid. Ewing sarcoma is a distinct small-round-cell malignancy that can arise in bone or soft tissue. Both can affect children or adolescents, but diagnosis and treatment differ. Most pediatric bone tumors arise outside the jaws.

Which findings suggest a malignant jaw lesion?

Progressive pain, swelling, tooth displacement or unexplained mobility, paresthesia, cortical destruction, or a persistent mass warrants prompt evaluation. Radiographs may show poorly defined lysis, mixed density, periosteal reaction, or soft-tissue extension. Infection and other lesions remain in the differential; imaging does not replace appropriately planned biopsy.

What oral effects can follow bone-tumor treatment?

Chemotherapy can cause mucositis, infection or bleeding vulnerability, and developing-tooth disturbances. Jaw surgery may affect function, appearance, growth, and rehabilitation. Radiation involving the jaws or salivary glands changes healing and caries risks. These effects depend on actual treatment; osteoradionecrosis is not expected simply because a bone cancer exists.

How should dental care be coordinated for a child with a malignant bone tumor?

Coordinate with oncology and the surgical team before invasive intervention near a suspected lesion. Assess and treat oral infection before therapy when feasible, prioritizing urgent disease within the cancer timetable. During treatment, use the child's protocol, recent counts, and current condition for procedural decisions. Afterward, plan prevention, developmental review, and prosthetic or surgical rehabilitation around the treatment field and growth.

What determines treatment and prognosis in malignant bone tumors?

Tumor type, stage, site, resectability, metastases, and response influence outcome. Osteosarcoma commonly requires chemotherapy and surgery; Ewing sarcoma uses systemic therapy with surgical or radiation-based local control. Localized and metastatic disease have different outlooks, so avoid applying one broad survival estimate.

Exam pearl

Sources

• Supplemental study guide: Pediatric malignant bone tumors
• AAPD: Management of Dental Patients with Special Health Care Needs (2026)
• NCI: Osteosarcoma and UPS of Bone Treatment (PDQ)
• NCI: Ewing Sarcoma Treatment (PDQ)
• AAPD: Dental Management During Immunosuppressive Therapy and Head and Neck Radiation (2026)